The HSU CIRM Bridges to Stem Cell Research Certificate Program
Grant Award Details
Grant Type:
Grant Number:
TB1-01190
Investigator(s):
Name:
Type:
PI
Award Value:
$3,195,858
Status:
Closed
Progress Reports
Reporting Period:
Year 4
Reporting Period:
Year 5
Reporting Period:
Year 6
Reporting Period:
Year 7
Grant Application Details
Application Title:
CIRM Bridges to Stem Cell Research Certificate Program
Public Abstract:
We are proposing a certificate program in stem cell biology research and regenerative medicine at our institution. Our objective is to train up to 30 students from diverse socioeconomic and ethnic background in the modern aspects of stem cell biology, it implications in regenerative medicine, and social and ethical issues in the use of stem cell technology. Specifically, the program will have two components. Students from our university will take the courses we offer in cellular and molecular biology. They will also complete at least one semester of independent research, which will enhance their training in experimental research design, basic methods, and good laboratory practices. The next phase of the program will require training in embryonic stem cell laboratory techniques at either [REDACTED] or [REDACTED], our “host” institutions. Up to ten undergraduates/year for three years will be selected to participate in a 12 month research internship at either [REDACTED] or at [REDACTED]. In preparation for these internships, trainees must show outstanding achievement in cellular and molecular biology coursework and aptitude in laboratory skills required to perform state of the art research techniques required in stem cell research. A general education course in Stem Cell Biology and Regenerative Medicine will be developed and offered to nonscience majors at our campus and at our local community college. A seminar series featuring researchers in the field from each host institution will be offered to our students and to the local medical community We will offer a weekend workshop in stem cell biology and research to biology educators in our community. Our efforts will help create a diverse, highly qualified work force in stem cell biology and an educated public prepared to benefit from the research our trainees contribute to.
Statement of Benefit to California:
Human embryonic stem cell biology has become an important component of biotechnology research. Scientists have predicted stem cells could be used to treat a myriad of ailments, including diabetes, neurological disorders, and multiple kinds of cancers. California has demonstrated support for this research by passing Proposition 71 to fund the California Institute for Regenerative Medicine (CIRM). Because of CIRM, cutting edge stem cell research is taking place in California. This research requires highly competent technicians and researchers to perform the laboratory work. Our program is designed to provide California students from diverse socioeconomic and ethnic backgrounds with comprehensive training in the modern aspects of stem cell biology, it implications in regenerative medicine, and social and ethical issues in the use of stem cell technology. Upon completion of coursework in genetics, cell biology, developmental biology, and stem cell laboratory methods, students will complete their training at at one of two "host" stem cell research centers: [REDACTED or at [REDACTED]. They will begin their training at these sites by taking a course in human embryonic stem cell research techniques. After completion of this course, they will participate in a 12 month research internship in a stem cell biology research laboratory. In addition to training students for careers in stem cell biology and regenerative medicine, we will increase the awareness of stem cell biology and regenerative medicine in our community by offering general education courses for non-science majors, by providing seminars, workshops, and grand rounds to local educators and medical professionals, and by sending our students into local high school classrooms to talk with students about stem cell biology and regenerative medicine. Our efforts will help create a diverse, highly qualified work force in stem cell biology and an educated public prepared to benefit from the research our trainees contribute to.
Publications
- Mol Cancer Res (2018): Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma. (PubMed: 29431617)
- Nat Med (2020): Articular cartilage regeneration by activated skeletal stem cells. (PubMed: 32807933)
- Stem Cells (2016): Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling. (PubMed: 26782178)
- Cell Stem Cell (2016): CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. (PubMed: 26971820)
- Mol Ther Methods Clin Dev (2017): DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B. (PubMed: 29159199)
- Tissue Eng Part A (2012): Effective delivery of stem cells using an extracellular matrix patch results in increased cell survival and proliferation and reduced scarring in skin wound healing. (PubMed: 23072446)
- Methods Mol Biol (2012): Exploring the link between human embryonic stem cell organization and fate using tension-calibrated extracellular matrix functionalized polyacrylamide gels. (PubMed: 22914951)
- Biol Reprod (2016): Human Endometrial Fibroblasts Derived from Mesenchymal Progenitors Inherit Progesterone Resistance and Acquire an Inflammatory Phenotype in the Endometrial Niche in Endometriosis. (PubMed: 27075616)
- Cell (2018): Identification of the Human Skeletal Stem Cell. (PubMed: 30241615)
- Nat Med (2019): Identification of preexisting adaptive immunity to Cas9 proteins in humans. (PubMed: 30692695)
- Nat Cell Biol (2011): Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. (PubMed: 21499256)
- Nat Protoc (2018): Isolation and functional assessment of mouse skeletal stem cell lineage. (PubMed: 29748647)
- Proc Natl Acad Sci U S A (2016): Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery. (PubMed: 27849590)
- Mol Ther Methods Clin Dev (2016): Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia. (PubMed: 27610394)
- Hum Mol Genet (2012): Signaling defects in iPSC-derived fragile X premutation neurons. (PubMed: 22641815)
- Proc Natl Acad Sci U S A (2012): Three differentiation states risk-stratify bladder cancer into distinct subtypes. (PubMed: 22308455)